We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Versarien Plc | AQSE:VRS.GB | Aquis Stock Exchange | Ordinary Share | GB00B8YZTJ80 | Ordinary shares |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.04 | 0.03 | 0.05 | 0.0417 | 0.04 | 0.04 | 250,000 | 16:29:45 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2023 to Jan 2025
TIDMVRS
RNS Number : 4431P
Versarien PLC
09 February 2023
9 February 2023
Versarien plc
("Versarien" or the "Company")
AIM Rule 17 Update
Versarien plc (AIM: VRS), the advanced materials engineering group, provides the following update in accordance with its disclosure obligations required under Rule 17 of the AIM Rules for Companies.
In a correction to the announcement of 7 January 2021, the Company advises that Dr Stephen Hodge, Chief Technology Officer, holds a beneficial interest in 46,774 ordinary shares of 1 pence each in the Company, acquired as part of Versarien's acquisition of Cambridge Graphene Limited in January 2017.
For further information please contact:
Versarien Plc Neill Ricketts - Chief Executive Officer +44 (0) 1594 887204 Chris Leigh - Chief Financial Officer Stephen Hodge - Chief Technology Officer SP Angel Corporate Finance (Nominated Adviser and Joint Broker) Matthew Johnson, Adam Cowl +44 (0) 20 3470 0470 Berenberg (Joint Broker) Mark Whitmore, Ciaran Walsh +44 (0) 20 3207 7800 IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen +44 (0) 20 3934 6630
About Versarien Plc
The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.
For further information please see: https://www.versarien.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCUKOWRORUURRR
(END) Dow Jones Newswires
February 09, 2023 03:33 ET (08:33 GMT)
1 Year Versarien Chart |
1 Month Versarien Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
